首页> 外文OA文献 >Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumour suppressor gene in neuroblastoma
【2h】

Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumour suppressor gene in neuroblastoma

机译:全基因组DNA甲基化分析鉴定 MEGF10 为神经母细胞瘤中一种新的表观遗传抑制的候选肿瘤抑制基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neuroblastoma is a childhood cancer in which many children still have poor outcomes, emphasising the need to better understand its pathogenesis. Despite recent genome-wide mutation analyses, many primary neuroblastomas do not contain recognisable driver mutations, implicating alternate molecular pathologies such as epigenetic alterations. To discover genes that become epigenetically deregulated during neuroblastoma tumorigenesis, we took the novel approach of comparing neuroblastomas to neural crest precursor cells, using genome-wide DNA methylation analysis. We identified 93 genes that were significantly differential methylation, of which 26 (28%) were hypermethylated and 67 (72%) were hypomethylated. Concentrating on hypermethylated genes to identify candidate tumour suppressor loci, we found the cell engulfment and adhesion factor gene to be epigenetically repressed by DNA hypermethylation or by H3K27 methylation in neuroblastoma cell lines. showed significantly down-regulated expression in neuroblastoma tumour samples; furthermore patients with the lowest-expressing tumours had reduced relapse-free survival. Our functional studies showed that knock-down of expression in neuroblastoma cell lines promoted cell growth, consistent with acting as a clinically relevant, epigenetically-deregulated neuroblastoma tumour suppressor gene.
机译:神经母细胞瘤是一种儿童期癌症,许多儿童的结局仍然很差,强调需要更好地了解其发病机理。尽管最近进行了全基因组突变分析,但许多原发性神经母细胞瘤不包含可识别的驱动程序突变,这暗示了其他分子病理学,例如表观遗传学改变。为了发现在神经母细胞瘤肿瘤发生过程中表观遗传失调的基因,我们采用了全基因组DNA甲基化分析比较神经母细胞瘤与神经rest前体细胞的新方法。我们鉴定了93个甲基化差异显着的基因,其中26个(28%)被高甲基化,而67个(72%)被低甲基化。专注于高甲基化的基因,以确定候选的肿瘤抑制基因,我们发现神经母细胞瘤细胞系中的DNA甲基化或H3K27甲基化会明显抑制细胞吞噬和粘附因子基因。在神经母细胞瘤肿瘤样品中表达明显下调;此外,肿瘤表达最低的患者的无复发生存期降低。我们的功能研究表明,敲除神经母细胞瘤细胞系中的表达可促进细胞生长,这与临床上相关的,表观遗传学上取消了的神经母细胞瘤抑癌基因一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号